van Gerven J - Search Results

1

Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial.

Recourt K, van der Aart J, Jacobs G, de Kam M, Drevets W, van Nueten L, Kanhai K, Siebenga P, Zuiker R, Ravenstijn P, Timmers M, van Gerven J, de Boer P. Recourt K, et al. Among authors: van der aart j, van nueten l, van gerven j. J Psychopharmacol. 2020 Sep;34(9):1030-1042. doi: 10.1177/0269881120914206. Epub 2020 Apr 4. J Psychopharmacol. 2020. PMID: 32248747 Clinical Trial.

2

Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers.

Gijsman HJ, Van Gerven JM, Tieleman MC, Schoemaker RC, Pieters MS, Ferrari MD, Cohen AF, Van Kempen GM. Gijsman HJ, et al. Among authors: van gerven jm, van kempen gm. J Clin Psychopharmacol. 1998 Aug;18(4):289-95. doi: 10.1097/00004714-199808000-00007. J Clin Psychopharmacol. 1998. PMID: 9690694 Clinical Trial.

3

The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation.

van Steveninck AL, van Berckel BN, Schoemaker RC, Breimer DD, van Gerven JM, Cohen AF. van Steveninck AL, et al. Among authors: van gerven jm, van berckel bn. J Psychopharmacol. 1999;13(1):10-7. doi: 10.1177/026988119901300102. J Psychopharmacol. 1999. PMID: 10221355 Clinical Trial.

4

Cognitive performance and serotonergic function in users of ecstasy.

Verkes RJ, Gijsman HJ, Pieters MS, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJ, de Bruin D, Van de Wijngaart G, Van Gerven JM, Cohen AF. Verkes RJ, et al. Among authors: van gerven jm, van de wijngaart g. Psychopharmacology (Berl). 2001 Jan 1;153(2):196-202. doi: 10.1007/s002130000563. Psychopharmacology (Berl). 2001. PMID: 11205419 Clinical Trial.

5

Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers.

Gijsman HJ, van Gerven JM, de Kam ML, Schoemaker RC, Pieters MS, Weemaes M, de Rijk R, van der Post J, Cohen AF. Gijsman HJ, et al. Among authors: van gerven jm, van der post j. J Clin Psychopharmacol. 2002 Apr;22(2):183-9. doi: 10.1097/00004714-200204000-00012. J Clin Psychopharmacol. 2002. PMID: 11910264 Clinical Trial.

6

Saccadic peak velocity and EEG as end-points for a serotonergic challenge test.

Gijsman HJ, van Gerven JM, Verkes RJ, Schoemaker RC, Pieters MS, Pennings EJ, Hessing TJ, Cohen AF. Gijsman HJ, et al. Among authors: van gerven jm. Hum Psychopharmacol. 2002 Mar;17(2):83-9. doi: 10.1002/hup.374. Hum Psychopharmacol. 2002. PMID: 12404696 Clinical Trial.

7

Evaluation of tests of central nervous system performance after hypoxemia for a model for cognitive impairment.

van der Post J, Noordzij LA, de Kam ML, Blauw GJ, Cohen AF, van Gerven JM. van der Post J, et al. Among authors: van gerven jm. J Psychopharmacol. 2002 Dec;16(4):337-43. doi: 10.1177/026988110201600408. J Psychopharmacol. 2002. PMID: 12503833 Clinical Trial.

8

REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers.

Rijnbeek B, de Visser SJ, Franson KL, Cohen AF, van Gerven JM. Rijnbeek B, et al. Among authors: van gerven jm. J Psychopharmacol. 2003 Jun;17(2):196-203. doi: 10.1177/0269881103017002008. J Psychopharmacol. 2003. PMID: 12870567 Review.

9

The psychomotor effects of carbamazepine in epileptic patients and healthy volunteers.

Pieters MS, van Steveninck AF, Schoemaker RC, Kroon JM, van Gerven JM, Cohen AF. Pieters MS, et al. Among authors: van gerven jm, van steveninck af. J Psychopharmacol. 2003 Sep;17(3):269-72. doi: 10.1177/02698811030173007. J Psychopharmacol. 2003. PMID: 14513917 Clinical Trial.

10

No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity.

van der Post J, de Waal PP, de Kam ML, Cohen AF, van Gerven JM. van der Post J, et al. Among authors: van gerven jm. J Psychopharmacol. 2004 Mar;18(1):109-14. doi: 10.1177/0269881104042832. J Psychopharmacol. 2004. PMID: 15107193 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page